Effect of Recombinant Adenovirus-p53 Combined With Radiotherapy on Long-Term Prognosis of Advanced Nasopharyngeal CarcinomaYouyong Lu, Shanwen Zhang, Chuan-beng Chen et al.|Journal of Clinical Oncology|2008Cited by 122
[Treatment of head and neck squamous cell carcinoma by recombinant adenovirus-p53 combined with radiotherapy: a phase II clinical trial of 42 cases].Shanwen Zhang, Youyong Lu, Shaowen Xiao et al.|PubMed|2003Cited by 43
[Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma].Shanwen Zhang, Bo Xu, Shaowen Xiao et al.|PubMed|2005Cited by 30
Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal CarcinomaYusheng Jie, Ying Huang, Ning Zhang et al.|JAMA|2025Cited by 26
726. Clinical Trial of Recombinant Adenovirus-p53 (Gendicine) Combined with Radiotherapy in Nasopharyngeal Carcinoma PatientsShanwen Zhang, Bo Xu, Shaowen Xiao et al.|Molecular Therapy|2006Cited by 4